Deep Docking platform developed to accelerate structure-based drug discovery

Date Posted: 
2020-06-02
Deep Docking schematic

Dr. Cherkasov and his team just published a paper in ACS Central Science describing the development of a Deep Docking technology. This AI-based approach enables virtual screening (docking) of billions of molecular structures in a rapid, yet accurate fashion. Deep Docking provides up to 100-fold data reduction and 6000-fold data enrichment for candidate drug molecules. Among other applications, the developed AI-approach allowed rapid screening of 1.36 billion molecules against a critical drug target in COVID-19.

"Deep Docking: A Deep Learning Platform for Augmentation of Structure Based Drug Discovery" has been accessed >1,500 times in the two weeks since its publication. 

This work has been supported by a Canadian Cancer Society Research Institute (CCSRI) Impact Grant. F.G. would like to thank the Ermenegildo Zegna Founder’s scholarship program for financial support.

A World Class Centre

The Vancouver Prostate Centre (VPC) has a track record of success that has earned it a reputation as one of the world’s most respected cancer facilities. It is a National Centre of Excellence and a designated Centre of Excellence for Commercialization and Research.

Events

Father's Day Walk Run for Prostate Cancer https://www.thefathersdayrun.ca/

Father's Day Walk Run fundraiser - June 19, 2022

Our Centre has two fundraising teams (Burnaby and virtual) in The 2022 Father's Day Walk Run for Prostate Cancer on June 19, raising funds for Prostate Cancer Foundation BC - more information at the hyperlinks

Employment

Work at the Vancouver Prostate Centre

Tuesday, May 3, 2022

VCHRI News: Mapping the driver of prostate cancer

Representative regulatory network for a single androgen regulated gene. Using multiple experimental approaches can characterize the complex interplay between different DNA switches to turn genes on. Image taken from VCHRI News original story.
Tuesday, April 12, 2022

Dr. Nappi awarded NIH R37 MERIT grant for international multi-centre testicular cancer research

Dr. Nappi